Skip to main content
Erschienen in: Indian Journal of Surgical Oncology 1/2018

11.05.2017 | Original Article

Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India

verfasst von: Nootan Kumar Shukla, S. V Suryanarayana Deo, Pankaj Kumar Garg, N. M. L. Manjunath, Suman Bhaskar, V. Sreenivas

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of the present study was to provide insight into various demographic, clinical, and management profile of Indian patients with oral tongue squamous cell cancer (OTSCC). All the OTSCC patients who had undergone surgical treatment during 1995 to 2010 at a tertiary care center in North India were considered for the present study. The details of the patients were retrieved from a prospectively maintained computerized database. A total of 124 patients were included in the present study. Mean age of the patients was 50.4 ± 12.0 years. Lateral border of the tongue was the most common sub-site involved in 110 (88.7%) patients. Neck nodes were clinically palpable in 56.4% patients. Hemiglossectomy and anterior partial glossectomy were common surgical procedure undertaken in 57.2 and 25.8% patients. Negative resection margin was achieved in 97.5% patients. Pathological neck metastasis was seen in 40.3% patients. Occult neck metastasis was present in 25.9% patients among clinical N0 neck. At a mean follow-up of 29.8 months (SD 3.1), 20.1% developed disease relapse and 4.0% patients developed second primaries. Kaplan-Meier analysis estimated a 5-year disease-free survival of 81.5% and a 5 years overall survival of 78.6%. Cox proportional regression analysis predicted tumor size and number of positive nodes to be independent predictive variables for disease recurrence. Quality controlled surgery, coupled with adjuvant treatment when required, provides a safe and effective treatment of OTSCC with a good disease-free survival and loco-regional control.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013 [cited 2015 Jun 25]. Available from: http://globocan.iarc.fr Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013 [cited 2015 Jun 25]. Available from: http://​globocan.​iarc.​fr
2.
Zurück zum Zitat Krishnamurthy A, Ramshankar V (2013) Early stage oral tongue cancer among non-tobacco users--an increasing trend observed in a south Indian patient population presenting at a single centre. Asian Pac J Cancer Prev 14:5061–5065CrossRefPubMed Krishnamurthy A, Ramshankar V (2013) Early stage oral tongue cancer among non-tobacco users--an increasing trend observed in a south Indian patient population presenting at a single centre. Asian Pac J Cancer Prev 14:5061–5065CrossRefPubMed
4.
Zurück zum Zitat Kobayashi Y, Karasawa K, Komiya Y, Hanyu N, Okamoto M, Chang T-C et al (2007) Therapeutic results for 100 patients with cancer of the mobile tongue treated with low dose rate interstitial irradiation. Anticancer Res 27:1689–1692PubMed Kobayashi Y, Karasawa K, Komiya Y, Hanyu N, Okamoto M, Chang T-C et al (2007) Therapeutic results for 100 patients with cancer of the mobile tongue treated with low dose rate interstitial irradiation. Anticancer Res 27:1689–1692PubMed
5.
Zurück zum Zitat Bhalavat R, Mahantshetty U, Tole S, Jamema S (2009) Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers. J Cancer Res Ther 5:192CrossRefPubMed Bhalavat R, Mahantshetty U, Tole S, Jamema S (2009) Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers. J Cancer Res Ther 5:192CrossRefPubMed
6.
Zurück zum Zitat Thiagarajan S, Nair S, Nair D, Chaturvedi P, Kane SV, Agarwal JP et al (2014) Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol 109:639–644CrossRefPubMed Thiagarajan S, Nair S, Nair D, Chaturvedi P, Kane SV, Agarwal JP et al (2014) Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol 109:639–644CrossRefPubMed
7.
Zurück zum Zitat Süslü N, Hoşal AŞ, Aslan T, Sözeri B, Dolgun A (2013) Carcinoma of the oral tongue: a case series analysis of prognostic factors and surgical outcomes. J Oral Maxillofac Surg 71:1283–1290CrossRefPubMed Süslü N, Hoşal AŞ, Aslan T, Sözeri B, Dolgun A (2013) Carcinoma of the oral tongue: a case series analysis of prognostic factors and surgical outcomes. J Oral Maxillofac Surg 71:1283–1290CrossRefPubMed
8.
Zurück zum Zitat Fan K-H, Lin C-Y, Kang C-J, Huang S-F, Wang H-M, Chen EY-C et al (2007) Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys 67:453–461CrossRefPubMed Fan K-H, Lin C-Y, Kang C-J, Huang S-F, Wang H-M, Chen EY-C et al (2007) Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys 67:453–461CrossRefPubMed
9.
Zurück zum Zitat Chen T-C, Wang C-T, Ko J-Y, Lou P-J, Yang T-L, Ting L-L et al (2010) Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck. Head Neck 32:555–561CrossRefPubMed Chen T-C, Wang C-T, Ko J-Y, Lou P-J, Yang T-L, Ting L-L et al (2010) Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck. Head Neck 32:555–561CrossRefPubMed
10.
Zurück zum Zitat Lim YC, Choi EC (2007) Unilateral, clinically T2N0, squamous cell carcinoma of the tongue: surgical outcome analysis. Int J Oral Maxillofac Surg 36:610–614CrossRefPubMed Lim YC, Choi EC (2007) Unilateral, clinically T2N0, squamous cell carcinoma of the tongue: surgical outcome analysis. Int J Oral Maxillofac Surg 36:610–614CrossRefPubMed
11.
Zurück zum Zitat Mantsopoulos K, Psychogios G, Künzel J, Waldfahrer F, Zenk J, Iro H (2014) Primary surgical therapy for locally limited oral tongue cancer. BioMed Res Int 738716 Mantsopoulos K, Psychogios G, Künzel J, Waldfahrer F, Zenk J, Iro H (2014) Primary surgical therapy for locally limited oral tongue cancer. BioMed Res Int 738716
12.
Zurück zum Zitat Ganly I, Patel S, Shah J (2012) Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome. Cancer 118:101–111CrossRefPubMed Ganly I, Patel S, Shah J (2012) Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome. Cancer 118:101–111CrossRefPubMed
13.
Zurück zum Zitat Akhtar S, Ikram M, Ghaffar S (2007) Neck involvement in early carcinoma of tongue. Is elective neck dissection warranted? J Pak Med Assoc 57:305–307PubMed Akhtar S, Ikram M, Ghaffar S (2007) Neck involvement in early carcinoma of tongue. Is elective neck dissection warranted? J Pak Med Assoc 57:305–307PubMed
14.
Zurück zum Zitat Zhang T, Lubek JE, Salama A, Dyalram D, Liu X, Ord RA (2004) Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. J Oral Maxillofac Surg 72:406–414CrossRef Zhang T, Lubek JE, Salama A, Dyalram D, Liu X, Ord RA (2004) Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. J Oral Maxillofac Surg 72:406–414CrossRef
15.
Zurück zum Zitat Kokemueller H, Rana M, Rublack J, Eckardt A, Tavassol F, Schumann P et al (2011) The Hannover experience: surgical treatment of tongue cancer--a clinical retrospective evaluation over a 30 years period. Head Neck Oncol 3:27CrossRefPubMedPubMedCentral Kokemueller H, Rana M, Rublack J, Eckardt A, Tavassol F, Schumann P et al (2011) The Hannover experience: surgical treatment of tongue cancer--a clinical retrospective evaluation over a 30 years period. Head Neck Oncol 3:27CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Shiga K, Ogawa T, Sagai S, Kato K, Kobayashi T (2007) Management of the patients with early stage oral tongue cancers. Tohoku J Exp Med 212:389–396CrossRefPubMed Shiga K, Ogawa T, Sagai S, Kato K, Kobayashi T (2007) Management of the patients with early stage oral tongue cancers. Tohoku J Exp Med 212:389–396CrossRefPubMed
17.
Zurück zum Zitat Byers RM, El-Naggar AK, Lee YY, Rao B, Fornage B, Terry NH et al (1998) Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 20:138–144CrossRefPubMed Byers RM, El-Naggar AK, Lee YY, Rao B, Fornage B, Terry NH et al (1998) Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 20:138–144CrossRefPubMed
18.
Zurück zum Zitat Yuen AP, Lam KY, Wei WI, Lam KY, Ho CM, Chow TL et al (2000) A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma. Am J Surg 180:139–143CrossRefPubMed Yuen AP, Lam KY, Wei WI, Lam KY, Ho CM, Chow TL et al (2000) A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma. Am J Surg 180:139–143CrossRefPubMed
19.
Zurück zum Zitat D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529CrossRefPubMed D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529CrossRefPubMed
21.
Zurück zum Zitat Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944CrossRefPubMed Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944CrossRefPubMed
22.
Zurück zum Zitat Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB et al (2012) Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the Head & Neck. Int J Radiat Oncol Biol Phys 84:1198–1205CrossRefPubMedPubMedCentral Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB et al (2012) Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the Head & Neck. Int J Radiat Oncol Biol Phys 84:1198–1205CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre J-L, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952CrossRefPubMed Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre J-L, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952CrossRefPubMed
24.
Zurück zum Zitat Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843–850CrossRefPubMed Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843–850CrossRefPubMed
25.
Zurück zum Zitat Rodrigues PC, Miguel MCC, Bagordakis E, Fonseca FP, de Aquino SN, Santos-Silva AR et al (2014) Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg 43:795–801CrossRefPubMed Rodrigues PC, Miguel MCC, Bagordakis E, Fonseca FP, de Aquino SN, Santos-Silva AR et al (2014) Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg 43:795–801CrossRefPubMed
26.
Zurück zum Zitat Huang S-F, Kang C-J, Lin C-Y, Fan K-H, Yen T-C, Wang H-M et al (2008) Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer 112:1066–1075CrossRefPubMed Huang S-F, Kang C-J, Lin C-Y, Fan K-H, Yen T-C, Wang H-M et al (2008) Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer 112:1066–1075CrossRefPubMed
27.
Zurück zum Zitat Shim SJ, Cha J, Koom WS, Kim GE, Lee CG, Choi EC et al (2010) Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol Lond Engl 5:43CrossRef Shim SJ, Cha J, Koom WS, Kim GE, Lee CG, Choi EC et al (2010) Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol Lond Engl 5:43CrossRef
28.
Zurück zum Zitat Baek C-H, Son Y-I, Jeong H-S, Chung MK, Park K-N, Ko Y-H et al (2008) Intraoral sonography-assisted resection of T1-2 tongue cancer for adequate deep resection. Otolaryngol--Head Neck Surg 139:805–810CrossRefPubMed Baek C-H, Son Y-I, Jeong H-S, Chung MK, Park K-N, Ko Y-H et al (2008) Intraoral sonography-assisted resection of T1-2 tongue cancer for adequate deep resection. Otolaryngol--Head Neck Surg 139:805–810CrossRefPubMed
29.
Zurück zum Zitat Kodama M, Khanal A, Habu M, Iwanaga K, Yoshioka I, Tanaka T et al (2010) Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas. J Oral Maxillofac Surg 68:1746–1752CrossRefPubMed Kodama M, Khanal A, Habu M, Iwanaga K, Yoshioka I, Tanaka T et al (2010) Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas. J Oral Maxillofac Surg 68:1746–1752CrossRefPubMed
Metadaten
Titel
Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India
verfasst von
Nootan Kumar Shukla
S. V Suryanarayana Deo
Pankaj Kumar Garg
N. M. L. Manjunath
Suman Bhaskar
V. Sreenivas
Publikationsdatum
11.05.2017
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 1/2018
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-017-0658-x

Weitere Artikel der Ausgabe 1/2018

Indian Journal of Surgical Oncology 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.